Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

Bibliographic Details
Main Authors:	Pluijm Saskia M F, Wulffraat Nico M, Heijstek Marloes W, Bulatović Maja, Van Dijkhuizen Pieter E H, de Jonge Robert
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008-09-01)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
by: van Wijk Femke, et al.
Published: (2011-09-01)

Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
by: Ćalasan Maja, et al.
Published: (2012-11-01)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008-09-01)

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
by: Rosanne M. Smits, et al.
Published: (2020-02-01)

Patient’s experiences with the care for juvenile idiopathic arthritis across Europe
by: E. H. Pieter. van Dijkhuizen, et al.
Published: (2018-02-01)

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
by: Maurits C F J de Rotte, et al.
Published: (2018-01-01)

Methotrexate in the combination therapy of juvenile idiopathic arthritis
by: E. S. Zholobova, et al.
Published: (2018-09-01)

Feasibility of quantitative sensory testing in juvenile idiopathic arthritis
by: Maarten O. Mensink, et al.
Published: (2022-08-01)

Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis
by: Sytze de Roock, et al.
Published: (2023-04-01)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
by: Serena ePastore, et al.
Published: (2015-03-01)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017-06-01)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
by: Novik GA, et al.
Published: (2011-09-01)

POSSIBLE PARENTERAL METHOTREXATE APPLICATION IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Yu. М. Spivakovsky, et al.
Published: (2014-12-01)

3019 Metabolomic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis
by: Ryan Sol Funk, et al.
Published: (2019-03-01)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
by: Reima Bakry, et al.
Published: (2022-10-01)

Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors
by: Estefanía Barral Mena, et al.
Published: (2020-03-01)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
by: Tzaribachev N, et al.
Published: (2008-09-01)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-09-01)

Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
by: Casper G. Schoemaker, et al.
Published: (2020-04-01)

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
by: Julia E. Möhlmann, et al.
Published: (2024-05-01)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
by: Anders Öman, et al.
Published: (2021-04-01)

EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-04-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Challenging the silent temporomandibular joint paradigm in children with juvenile idiopathic arthritis
by: Willemijn F. C. de Sonnaville, et al.
Published: (2022-04-01)

Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis
by: Ezgi Deniz Batu, et al.
Published: (2017-02-01)

Glutathione S-Transferase Gene Polymorphisms as Predictors of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
by: Sanda Huljev Frkovic, et al.
Published: (2024-07-01)

Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
by: Nini Kyvsgaard, et al.
Published: (2021-04-01)

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019-10-01)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
by: V. A. Keltsev, et al.
Published: (2016-01-01)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
by: V. A. Kel'tsev, et al.
Published: (2015-04-01)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomien A, et al.
Published: (2012-08-01)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomine A, et al.
Published: (2012-08-01)

EXPERIENCE OF INTRAMUSCULAR METHOTREXATE USE IN A PATIENT WITH EARLY POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF HYPODERMIC METHOTREXATE INJECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
by: van den Berg JM, et al.
Published: (2011-09-01)

EXPERIENCE OF THE EFFICIENT USING OF METHOTREXATE FOR SUBCUTANEOUS ADMINISTRATION IN PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: S. A. Ushakova, et al.
Published: (2014-07-01)

Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
by: Nini Kyvsgaard, et al.
Published: (2019-01-01)

Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
by: Gabriella Giancane, et al.
Published: (2019-07-01)

EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-03-01)